ClinConnect ClinConnect Logo
Search / Trial NCT06611501

Glycemic Regulation as Endometriosis Adjunct Treatment

Launched by BOSTON CHILDREN'S HOSPITAL · Sep 20, 2024

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Pelvic Pain Pain Metformin Chronic Pain Physiological Effects Of Drugs Endometriosis Female Urogenital Diseases Genital Diseases, Female

ClinConnect Summary

This clinical trial, called "Glycemic Regulation As Endometriosis Adjunct Treatment," is looking at whether a medication called metformin can help reduce pelvic pain in young women with endometriosis. The study aims to find out if metformin is more effective than a placebo (a harmless look-alike pill) in relieving pain and whether it can change certain markers of inflammation in the body over a period of six months.

To participate in this trial, you need to be a female between the ages of 15 and 35 who has been diagnosed with endometriosis through surgery and has been experiencing pelvic pain for at least two months. Participants will take either metformin or the placebo daily for six months and will visit the clinic three times during the study to check on progress. They will also keep a daily diary to record their pain levels and any medication they use. It's important to note that this trial is not yet recruiting participants, but it may be a useful option for those who qualify.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female with surgically confirmed endometriosis, determined at laparoscopy
  • Current use for at least 2 months duration of a consistent hormonal therapy for endometriosis (either combination hormonal contraceptives or progestin-only therapy)
  • Current pelvic pain (score ≥ 3 on Visual Analog Scale) that has been present for at least 2 months prior to enrollment
  • Age 15 years to 35 years and premenopausal
  • Willingness to comply with visit schedule and protocol
  • Exclusion Criteria:
  • Pre-menarche or post-menopause
  • Diagnosis of Type 1 or Type 2 Diabetes Mellitus
  • Severe renal dysfunction (creatinine \>1.4 mg/dL or eGFR below 45 mL/minute/1.73 m2
  • History of lactic acidosis or diabetic ketoacidosis
  • ALT or AST \> 2.5 times the upper limit of normal
  • Significant mental or chronic systemic illness that might confound pain assessment or the inability to complete the study
  • Current/planning pregnancy or breastfeeding
  • Inability to read English

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Jessica Shim, MD

Principal Investigator

Boston Children's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported